SQLite Web: event_store.db

Update row 13865 in events

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-10T03:04:31.796915+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:99d8fafba535e7ff","evidence_event_ids":["evt_7ba6e854391a"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1683553/0001193125-26-149821.txt","as_of":"2026-04-10T03:04:31.796915+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1683553/0001193125-26-149821.txt","company":"SPRUCE BIOSCIENCES, INC.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1683553/0001193125-26-149821.txt","article_chars":4999,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_2a60bd331c30863a","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1683553/0001193125-26-149821.txt","content_type":"text/plain","enriched_at":"2026-04-10T03:33:14.453443+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"DEF 14A","final_url":"https://www.sec.gov/Archives/edgar/data/1683553/0001193125-26-149821.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1683553/0001193125-26-149821.txt","source_event_id":"evt_7ba6e854391a","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEF 14A","fp":"0da35f9982eaa427","kind":"sec_filing","published_at":"20260409","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-10","2026-05-21","2024-01-01","2024-12-31","2025-01-01","2025-12-31","2025-12-11"],"entities":[{"asset_class":"equity","name":"Spruce Biosciences, Inc.","relevance":"high","symbol":"SPRB","type":"issuer"},{"asset_class":"unknown","name":"Javier Szwarcberg","relevance":"medium","symbol":"","type":"person"},{"asset_class":"unknown","name":"Samir Gharib","relevance":"medium","symbol":"","type":"person"},{"asset_class":"unknown","name":"Kirk Ways","relevance":"medium","symbol":"","type":"person"}],"event_type":"listing","information_gaps":["No explicit comparison to a prior known state is provided in the excerpt (what changed vs prior filings is not stated).","The excerpt does not include the full proxy statement content (e.g., proposals, voting matters, director nominees, compensation totals, or specific equity award amounts).","The equity award-related table fields appear, but the cleaned text does not show the underlying numeric values or the exact context of those fields beyond labels."],"key_facts":["The SEC filing is a Schedule 14A proxy statement and is marked as a definitive proxy statement.","The registrant is Spruce Biosciences, Inc. (SPRB).","The notice states the 2026 Annual Meeting of Stockholders will be held on May 21, 2026 at 10:00 a.m. (Pacific Time).","The notice states the meeting will be held through a live webcast at www.virtualshareholdermeeting.com/SPRB2026 and that stockholders will not be able to attend in person.","The filing indicates \u201cNo fee required.\u201d for the payment of filing fee section.","The provided text includes multiple equity award-related fields referencing individuals (e.g., Javier Szwarcberg, Samir Gharib, Kirk Ways) and dates/valuation periods (e.g., 2024-01-01 to 2024-12-31 and 2025-01-01 to 2025-12-31), but the specific numeric values are not present in the cleaned excerpt."],"numeric_claims":[],"primary_claim":"SPRB (Spruce Biosciences, Inc.) filed a definitive proxy statement on Form DEF 14A (Schedule 14A) on 2026-04-10.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Spruce Biosciences, Inc. filed a definitive proxy statement on Schedule 14A (DEF 14A) for its 2026 annual meeting of stockholders. The filing includes notice details for a May 21, 2026 meeting and contains executive equity award valuation-related table fields.","topics":["SEC filing","DEF 14A","proxy statement","annual meeting","executive compensation/equity awards"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEF 14A \u00b7 SPRUCE BIOSCIENCES, INC. \u00b7 Filed 20260409","ticker":"SPRB","tickers":["SPRB"],"title":"SPRB filed DEF 14A","url":"https://www.sec.gov/Archives/edgar/data/1683553/0001193125-26-149821.txt"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel